MAP solution

contains mannitol, adenine, glucose, phosphate and citrate; a new additive solution, may be useful for autologous blood transfusion

Also Known As:

MAP-CRC solution

Networked: 3 relevant articles (1 outcomes, 1 trials/studies)

1.	Hemolysis 04/01/2014 - "The MAP solution helps preserve RBC morphology and function, and reduces hemolysis, possibly due to improved energy production. " 07/01/2005 - "Mannitol (80 mM) is used to inhibit hemolysis as a constituent of MAP solution, which is a solution used for the storage of RBC products in Japan. "
2.	Neoplasms (Cancer) 02/01/2014 - "The purpose of the current study was to develop an approximation for the CIMPLE map solution for short-interval scanning involving the assumption that net intervoxel tumor invasion does not occur within sufficiently short time frames. "